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The major goal of our laboratory is to elucidate the molecular basis of the activity of various
bioactive substances by biochemical, physicochemical, and synthetic approaches.  These include
studies on the mechanism of sequence-specific DNA cleavage by antitumor or carcinogenic
molecules, studies on the DNA recognition of zinc-finger proteins, and model studies on the action
of ion channels.  In addition, artificial designed peptides have also been developed as useful tools






To understand the molecular basis for unique
biological activity of C-1027, three-dimensional
structures of DNA-Chr complex, Apo-Chr complex, and
free Chr are essential.  We clarified solution structures
of free Chr and the complex formed between the drug
and DNAoligomer by NMR techniques.  The NOESY
measurements of Chr-DNA oligomer complex yielded a
total of 144 DNA intramolecular, 33 drug-intramolecular,
and 36 DNA-drug intermolecular NOEs that we were
able to clearly assign.  Free Chr in D2O solution provided
Antitumor antibiotic C-1027 that is regarded as a natural model of drug delivery system, consists of a
carrier apoprotein (Apo) and an enediyne chromophore (Chr).  We have compared three solution structures
of the DNA-Chr complex, Apo-Chr complex, and free Chr determined by high-resolution NMR
experiments.  The guest molecule, C-1027 chromophore, showed two distinct binding modes fitted to
binding sites of the hosts (target DNA and carrier Apo).  The novel Chr interacts with DNA through its
benzoxazolinate and aminosugar moieties, and also with Apo through the benzoxazolinate and macrocyclic
moieties.  The superposition of Chrs in these three states clearly revealed conformational deviation of the
16-membered macrocyclic moiety containing intra-chlorophenol ring.  Ab initio calculations supported
good correlation between the reactivity and the conformational alteration of Chr induced in hosts.  The
present results provide molecular basis and implication for the host-recognition mode, the reaction
mechanism, and drug delivery system of chromoprotein C-1027.
14 intramolecular ROES in the ROESY.  The solution
structures of DNA-Chr complex and free Chr obtained
with distance-restrained molecular dynamics
computations gave relevant modeds that are fully
consistent with the observed NMR-derived distance date.
In the unbound state, restrained molecular dynamics
simulation illustrated that free Chr can't fix its
benzoxazolinate (BO) and aminosugar (AS) moieties in
one specific monfomation without characteristic
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rarely detected.  Since most of observed intra-ROEs of
Chr arose from the 16-membered macrocyclic part (MC),
the conformation of  MC was restrained.  Average pairwise
RMS deviations among final structures were 0.75 Å for
the DNA-Chr complex and 0.77 Å for free Chr.  The
generated structures of DNA-Chr complex and free Chr
were averaged and energy-minimized.
In the Chr-DNA heptamer complex, the inter-NOEs
of BO and AS moieties with DNA were in the majority
(75%) of  all observed intermolecular peaks.  The proton
chemical shit perturbations of these functionla moieties
were also large upon binding to DNA.  Thus, both the BO
and AS parts play important roles for the recognition and
binding of Chr to DNA.  The DNA-Chr complex model
evidently revealed that C1027-Chr interacts with each
tetranucleotide of the d(C3C4A5T6)/d(A0T10G11G12)
duplex through unique intercalation of the BOmoiety at
the d(C3C4)/d(G11G12) step and also minor groove
binding of the AS part at d(A5T6)/d(Q9T10G11).  This
complex is stabilized by the stacking interaction through
intercalation and by the backbone helical and minor
groove contacts through van der Waals interactions.  The
intercalation of the BO moiety was demonstrated by the
NOEs connecting 1"-NH with H6, H1', H2', 2" of C3 and
H6, NH2 of C4; OMe with H8, H1, H1' of G11; H6" with
H3' of G12.  One of the two six-membered  rings of C3
and C4, while the one containing methoxy group stacks
on the purine rings of G11 and G12.  The protruding
methoxy group of BO moiety makeds van der Waals
contacts with H1' of G11 sugar.  Furhermore, the inter-
NOEs of the AS moiety with the DNA oligomer were
obzerved connecting of β-Hs (H2', H3', H4', and 5'-Meβ)
with H1' and H4' of T6 and H2 of A5; α-Hs (4'-NMe and
5'-Meα) with H2 of A9, H1' and H4' of T10  and H4', H5',
and H5" of G11.  There are backbone heical sugur-
phosphate backbones of A5T6 and A9T10G11strands on
other side.  The orientation of the AS moiety permits its
α
1Hs and β1HS to face toward the A9T10-strand and
A5T6-strand, respectively.  A set of contacts between Chr
and DNA minor groove floor was detected.  These contacts
include van der Waals interaction of AS H3' with DNA
A5(H2) and A9(H2) and a hydrogen bond supports our
previous data that the guanine 2-amino group of the central
base in trinucleotide 5'-AGG plays a key role in the
recognition of the DNA oligomerby by Chr.  In addition,
the observation of several NOEs showed the backbone
helical binding between the aromatized AEB ring (H5,H6,
and H8) and the DNA backbone [C4(H1'), A5 (H1' and
H4'), and T6(H5')].  An intermolecular NOE cross peak
between Chr-H6 and A5-H1' or -H4' revealed the
prozimity of these protons.  The Chr-H3 is situated close
to H1' of G12, as indicated by the constructed model.
Therefore, it is reasonably proposed that the DNA lesions
caused by the C-1027 Chr are due to the abstraction of
hydrogen atoms from A5-C1' or -C4' by the Chr-C6 radical
and from G12--C1' by the Chr-C3 radical.  In fact, our
previous gel electrophoretic analysis evidently showed
that the DNA domage occurs at CCA/TGG with a two
nucleotide 3'-stagger of the reactive biradical atoms(C3
and C6) of the enediyne Chr to the vicinity of deoxyribose
hydrogen atoms (H1' or H4') of the DNA backbone (A5
and G12).  The AS assists in winding of the Chr around
the minor groove of the DNA oligomer.
We evaluated the influence of spatial configuration of
the neighboring aromatic ring on the reactivity of the
biradical by an ab initio method (23,24).  Recently, Chen
and co-workers pointed out that the reactivity of p-benzyne
type bieadicals depends upon the energy splitting between
the singlet (S) ground state and triplet (T) excited state;
the lager the S-T splitting becomes, the less reactive the
singlet biradical dose. On the basis of this information,
we istimated and conpared teh S-T splittings of both
biradical-aromatic ring systems that are confomationally
similar to C1027-Chrs in DNA and Apo.  The S-T splitting
of the biradical-aromaric ring system in DNA was slightly
smaller than that in Apo (Table III).  Accordingly, the p-
benzyne type biradical in DNA is more reactive than that
in Apo, because of the conformational alteration of the
MC part containing chlirophenoling.  It is possible for
the drug to control the reactivity of hydrogen-abstraction
reactions by subtle structural perturbation of the
intramolecular cholorphenol ring adjacent to the reacting
AEB system .  On the other band, neocarzinostatin (NCS),
esperamicin, calcheamicin, and kedarcidin require external
cofactor (thiol) as trigger of the Bergmann reaction.
